The study on the relationship between breast cancer screening and staging on diagnosis, survival medical utilization

• Main Authors: Tzu-Chin Cheng, 鄭資津
• Other Authors: Ying-Ying Lo
• Format: Others
• Language: zh-TW
• Published: 2016
• Online Access: http://ndltd.ncl.edu.tw/handle/72816346998121093138

碩士 === 義守大學 === 管理碩博士班 === 104 === Objective : The main purpose of research is to understand breast cancer patients, their diagnosis when screening for cancer staging, use of medical care and medical expenses of the relevance and viability. Methods: This retrospective study mining research, conducted a secondary data analysis, the use of a regional teaching hospital of January 1, 2011 to December 31 2013, Cancer Registry and medical records basic information, and Bureau of Health Promotion, Department of Health, R.O.C system is recognized as presence or absence of developing cancer. Before the cancer mammography screening for breast cancer during the study period a total of 471 cases, excluding 44 incomplete, effective sample of 427. The research tool uses IBM SPSS 18 Statistics were analyzed using descriptive statistics, chi-square test / T test (one-way analysis of variance), logistic regression, linear regression and K-M survival were analyzed. Result: The diagnosis of breast cancer in which the breast cancer screening ago to accept those who have 213, accounting for 49.88%, not those 214, accounting for 50.12%. Theresults of this study found that the population sample of variables related with breast cancer screening. The analysis showed that 50 to 65 years age at diagnosis was 50 years old to perform screening0.22 times. Performing a low level of education high screening rates at least 0.2 times the level of education. There are easier to find in situ breast cancer screening or the first part of another cancer, cancer screening by the Executive survival rate than those without screening were long. There is screening an average hospital stay of about 10.1 days,compared with no screening were 13.4 short days. There are other cases of comorbidity factors and screening for medical use significant contribution level. Conclusion: Early diagnosis of the study show a better prognosis, lower medical utilization and fewer medical costs, and also the promotion of health policy, provided by the national health insurance spending for breast cancer prevention and health care of the screening, Hope all the people involved. Finally, we expect to take an evidence in favor of the business of promoting breast cancer screening.